These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 28375515)

  • 1. Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.
    Geisinger E; Isberg RR
    J Infect Dis; 2017 Feb; 215(suppl_1):S9-S17. PubMed ID: 28375515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals.
    Mathlouthi N; Areig Z; Al Bayssari C; Bakour S; Ali El Salabi A; Ben Gwierif S; Zorgani AA; Ben Slama K; Chouchani C; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):335-41. PubMed ID: 25587875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.
    Navon-Venezia S; Ben-Ami R; Carmeli Y
    Curr Opin Infect Dis; 2005 Aug; 18(4):306-13. PubMed ID: 15985826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.
    Bonnin RA; Nordmann P; Poirel L
    Expert Rev Anti Infect Ther; 2013 Jun; 11(6):571-83. PubMed ID: 23750729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the resistant genes to carbapenems and epidemiological characterization of multidrug-resistant Acinetobacter baumannii isolates.
    Jiang W; Liu H; Zhong M; Yang YC; Xiao DW; Huang WF
    Microb Drug Resist; 2013 Apr; 19(2):117-23. PubMed ID: 22845773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Saliva of Burn ICU Patients for Resistant Infections Harbor Metallo-β-Lactamase Genes.
    Emami A; Pirbonyeh N; Keshavarzi A; Bazargani A; Hassanpour S; Javanmardi F
    J Burn Care Res; 2020 May; 41(3):647-651. PubMed ID: 31930340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
    Zavascki AP; Carvalhaes CG; Picão RC; Gales AC
    Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
    Shanthi M; Sekar U
    J Assoc Physicians India; 2009 Sep; 57():636, 638-40, 645. PubMed ID: 20214000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
    Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Activity of the Novel Antimicrobial Peptide Dendrimer G3KL against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Pires J; Siriwardena TN; Stach M; Tinguely R; Kasraian S; Luzzaro F; Leib SL; Darbre T; Reymond JL; Endimiani A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7915-8. PubMed ID: 26459893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Future" threat of gram-negative resistance in Singapore.
    Tan TT
    Ann Acad Med Singap; 2008 Oct; 37(10):884-90. PubMed ID: 19037523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4.
    Supp DM; Gardner J; Klingenberg JM; Neely AN
    Burns; 2009 Nov; 35(7):949-55. PubMed ID: 19501982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.
    El Zowalaty ME; Al Thani AA; Webster TJ; El Zowalaty AE; Schweizer HP; Nasrallah GK; Marei HE; Ashour HM
    Future Microbiol; 2015; 10(10):1683-706. PubMed ID: 26439366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of carbapenemase production among gram-negative bacteria in saudi arabia.
    Memish ZA; Assiri A; Almasri M; Roshdy H; Hathout H; Kaase M; Gatermann SG; Yezli S
    Microb Drug Resist; 2015 Jun; 21(3):307-14. PubMed ID: 25569024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.
    Bonomo RA; Szabo D
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S49-56. PubMed ID: 16894515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
    Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML
    Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic-resistant bacteria and new directions of antimicrobial chemotherapy].
    Tateda K
    Rinsho Byori; 2012 May; 60(5):443-8. PubMed ID: 22774573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.